Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Maximilian Mamot, MSc"'
Autor:
Till Wallrabenstein, MD, Maximilian Mamot, MSc, Eveline Daetwyler, MD, David König, MD, Sacha I. Rothschild, MD, PhD
Publikováno v:
JTO Clinical and Research Reports, Vol 4, Iss 5, Pp 100509- (2023)
Introduction: On the basis of the landmark trial KEYNOTE-189 (KN-189), pembrolizumab plus chemotherapy has become the standard-of-care first-line treatment for patients with advanced nonsquamous NSCLC without oncogenic driver alterations.KN-189 inclu
Externí odkaz:
https://doaj.org/article/28b5722b324a48098ada0dc31a3f7a76